Cargando…
Drug Resistance of CPT-11 in Human DLD-1 Colorectal Cancer Cells through MutS Homolog 2 Upregulation
Colorectal cancers (CRCs) is the most commonly diagnosed and deadly cancer types in the world. Despite advances in chemotherapy for CRCs, drug resistance remains a major challenge to high incurable and eventually deadly rates for patients. CPT-11 is one of the current chemotherapy agents for CRC pat...
Autores principales: | Lee, Ko-Chao, Yen, Chia-Kung, Chen, Cheng-Nan, Chang, Shun-Fu, Lu, Ying-Chen, Huang, Wen-Shih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847627/ https://www.ncbi.nlm.nih.gov/pubmed/33526988 http://dx.doi.org/10.7150/ijms.52620 |
Ejemplares similares
-
Analysis of human MutS homolog 2 missense mutations in patients with colorectal cancer
por: Zhang, Xiaomei, et al.
Publicado: (2018) -
Overexpression of MutL homolog 1 and MutS homolog 2 proteins have reversed prognostic implications for stage I–II colon cancer patients
por: Huang, Shih-Chiang, et al.
Publicado: (2017) -
6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level
por: Lee, Ko-Chao, et al.
Publicado: (2021) -
MutL homolog 1 methylation and microsatellite instability in sporadic colorectal tumors among Filipinos
por: Cabral, Loraine Kay D, et al.
Publicado: (2021) -
Pharmacological Correlation between Total Drug Concentration and Lactones of CPT‐11 and SN‐38 in Patients Treated with CPT‐11
por: Sasaki, Yasutsuna, et al.
Publicado: (1995)